SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,992,000 | +21.6% | 158,677 | +0.8% | 0.02% | -45.5% |
| Q3 2020 | $3,282,000 | +1.1% | 157,477 | +15.2% | 0.04% | +76.0% |
| Q2 2020 | $3,247,000 | -99.9% | 136,735 | -2.7% | 0.02% | 0.0% |
| Q1 2020 | $2,528,000,000 | -30.9% | 140,535 | -8.8% | 0.02% | +4.2% |
| Q4 2019 | $3,656,000,000 | +39039.3% | 154,135 | -54.7% | 0.02% | -63.1% |
| Q3 2019 | $9,341,000 | -33.8% | 339,910 | -20.2% | 0.06% | -33.0% |
| Q2 2019 | $14,103,000 | -28.4% | 426,210 | -24.2% | 0.10% | -30.2% |
| Q1 2019 | $19,705,000 | -4.7% | 562,360 | -9.7% | 0.14% | -20.6% |
| Q4 2018 | $20,678,000 | +5.5% | 622,460 | +59.9% | 0.18% | +24.1% |
| Q3 2018 | $19,603,000 | -25.1% | 389,335 | -11.0% | 0.14% | -31.6% |
| Q2 2018 | $26,184,000 | +237.4% | 437,500 | +158.2% | 0.21% | +243.3% |
| Q1 2018 | $7,761,000 | – | 169,475 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |